Current German DRG (diagnosis related groups) system "threatens innovation"
This article was originally published in Clinica
Germany's new diagnosis related groups (DRG) system for hospital reimbursement is threatening the adoption of innovative medical technology into the health service because it focuses too heavily on financial costs, claims Bernhard Rochell, DRG expert at the federal doctors' chamber (BAK). Speaking last week in Berlin, he said that at present it appeared that hospitals and sickness funds were "pulling at opposite ends of the same rope". He advised: "For new procedures we need qualitative arguments, especially where costs are seen to rise."
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.